LD-2 disclosure · 1st Quarter - Report
SAREPTA THERAPEUTICS, INC.
via SAREPTA THERAPEUTICS, INC.
Client
- Name
- SAREPTA THERAPEUTICS, INC.
- Location
- California · United States of America
Registrant
- Firm
- SAREPTA THERAPEUTICS, INC.
- Description
- Biopharmaceutical company
- Location
- Sausalito, California, United States of America
Lobbying activities
3 issuesHealth Issues
Issues related to patient access to treatments Issues related to rare diseases, including Duchenne Muscular Dystrophy Issues related to newborn screening for rare diseases Issues related to scientific innovation in healthcare, including gene therapies Public Law 117-169, Inflation Reduction Act of 2022; Provisions related to prescription drugs
Lobbyistsmr KIP PAYNE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Taxation/Internal Revenue Code
Tax issues related to research and development
Lobbyistsmr KIP PAYNE
TargetedSENATE · HOUSE OF REPRESENTATIVES
Science/Technology
Issues related to artificial intelligence and data governance
Lobbyistsmr KIP PAYNE
TargetedSENATE · HOUSE OF REPRESENTATIVES